From April 1, 2024 to June 30, 2024, the company has repurchased 596,900 shares, representing 0.43% for CNY 19.63 million. With this, the company has completed the repurchase of 1,226,200 shares, representing 0.88% for CNY 37.49 million under the buyback announced on February 19, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.24 CNY | +1.92% | +1.60% | -19.24% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.24% | 425M | |
+25.83% | 47.96B | |
+45.38% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- 301230 Stock
- News PharmaResources (Shanghai) Co., Ltd.
- Tranche Update on PharmaResources Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.